Central Nervous System Mediation of Growth Hormone Secretagogue in the Pig

Rapid growth in the young pig requires an episodic pattern of growth hormone (GH) secretion. We developed different neurosurgical techniques to elucidate sites within the hypothalamus, a lower part of the brain, that regulate GH release in this species. A focus of this research is administration of small brain peptide and nonpeptide hormones that acutely affect GH release to define mechanisms of action and their efficacy in augmenting growth

Comparative Ovarian and Pituitary Hormone Secretion in Pregnant Meishan and Yorkshire Gilts

Chinese Meishan and Yorkshire were used to investigate mechanisms regulating the production and secretion of relaxin, progesterone, prolactin (PRL), and growth hormone (GH) during late pregnancy and lactation. Uterine surgical removal (hysterectomy) of nongravid gilts during the estrous cycle (day 8) extends luteal function to 150 days which is beyond the duration of normal pregnancy. Hysterectomy provides a useful model to examine shifts in hormone secretion at the time of expected parturition in gravid pigs. Blood samples were collected via an indwelling jugular cannula twice daily (0800 and 2000 hours) from days 90 to 120 and every 20 minutes within a 3-hour period on days 112 to 116. Relaxin and progesterone are hormones of ovarian origin, and PRL and GH are hormones secreted by the pituitary gland. Parturition occurred earlier (day 114) in Yorkshire than Meishan (day 115) gilts. The prepartum peak relaxin release occurred about 16 hours earlier in both breeds, thereafter relaxin dropped to basal levels during lactation. After hysterectomy, relaxin plasma levels were consistently greater in Meishan compared with Yorkshire gilts from days 110-118. A programmed peak relaxin release occurred one day earlier in Yorkshire compared with Meishan gilts. Following the relaxin peak, corpora lutea persisted in both breeds, but Meishan gilts continued to secrete consistently greater amounts of relaxin than Yorkshire gilts. Progesterone plasma levels remained higher longer in late pregnant Meishan compared with Yorkshire gilts. After hysterectomy, progesterone plasma levels were consistently higher in Meishan compared with Yorkshire gilts from days 101 to 118. Prolactin circulating concentration increased during late pregnancy and early lactation, but at a higher level in Yorkshire compared with Meishan gilts. Growth hormone blood levels increased only during late pregnancy and early lactation in both Meishan and Yorkshire gilts. These results indicate significant differences in the timing, and in some cases, magnitude of hormone secretion profiles in pregnant and hysterectomized Yorkshire and Meishan gilts

The Genome Sequence of 'Mycobacterium massiliense' Strain CIP 108297 Suggests the Independent Taxonomic Status of the Mycobacterium abscessus Complex at the Subspecies Level

Members of the Mycabacterium abscessus complex are rapidly growing mycobacteria that are emerging as human pathogens. The M. abscassus complex was previously composed of three species, namely M. abscessus sensu strict, 'M. massiliense', and M. bolletii', In 2011, 'M. massiliense' and 'M. bolletre' were united and reclassified as a single subspecies within M. abscessus: M. abscessus subsp. bolletii. However, the placement of 'M. massiliense' Within the boundary of M. abscessus subsp. balletii remains highly controversial with regard to clinical aspects. In this study, we revisited the taxonomic status of members of the M. abscessus complex based on comparative analysis of he whole-genome sequences of 53 strains, The genome sequence of the previous type strain of 'Mycobacterium massiliense' (CIP 108297) was determined using next-generation sequencing. The genome tree based on average nucleotide identity (AN I) values supported the differentiation of M. bolletii' and M. massiliense' at the subspecies level. The genome tree also clearly illustrated that 'M. bolletil' and 'M. massiliense' form a distinct phylogenetic clade within the radiation of the M. abscessus complex. The genomic distances observed in this study suggest that the current M. abscessus subsp. bolletii taxon should be divided into two subspecies, M. abscessus subsp. massiliense subsp. nov. and M. abscessus subsp. bolletii, to correspondingly accommodate the previously known 'M. assiliense' and 'M. bolletii' strains.

Angleâ Insensitive and CMOSâ Compatible Subwavelength Color Printing

Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/134900/1/adom201600287_am.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134900/2/adom201600287.pdfhttp://deepblue.lib.umich.edu/bitstream/2027.42/134900/3/adom201600287-sup-0001-S1.pd

Clarithromycin Susceptibility Testing of Mycobacterium avium Complex Using 2,3-Diphenyl-5-thienyl-(2)-tetrazolium Chloride Microplate Assay with Middlebrook 7H9 Broth

A series of 119 Mycobacterium avium complex isolates were subjected to clarithromycin susceptibility testing using microplates containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride (STC). Among 119 isolates, 114 (95.8%) were susceptible to clarithromycin and 5 were resistant according to the new and the standard method. STC counts the low cost and reduces the number of procedures needed for susceptibility testing

Biological Brain Age Prediction Using Cortical Thickness Data: A Large Scale Cohort Study

Brain age estimation from anatomical features has been attracting more attention in recent years. This interest in brain age estimation is motivated by the importance of biological age prediction in health informatics, with an application to early prediction of neurocognitive disorders. It is well-known that normal brain aging follows a specific pattern, which enables researchers and practitioners to predict the age of a human's brain from its degeneration. In this paper, we model brain age predicted by cortical thickness data gathered from large cohort brain images. We collected 2,911 cognitively normal subjects (age 45–91 years) at a single medical center and acquired their brain magnetic resonance (MR) images. All images were acquired using the same scanner with the same protocol. We propose to first apply Sparse Group Lasso (SGL) for feature selection by utilizing the brain's anatomical grouping. Once the features are selected, a non-parametric non-linear regression using the Gaussian Process Regression (GPR) algorithm is applied to fit the final age prediction model. Experimental results demonstrate that the proposed method achieves the mean absolute error of 4.05 years, which is comparable with or superior to several recent methods. Our method can also be a critical tool for clinicians to differentiate patients with neurodegenerative brain disease by extracting a cortical thinning pattern associated with normal aging

A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer

BACKGROUND: In non-small cell lung cancer (NSCLC), interstitial hypertension is a barrier to chemotherapy delivery, and is mediated by platelet derived growth factor receptor (PDGFR). Antagonizing PDGFR with imatinib may improve intra-tumoral delivery of paclitaxel, increasing response rate (RR). METHODS: This single-stage, open-label phase II study evaluated pulse dose imatinib and weekly paclitaxel in elderly patients with advanced NSCLC. Eligible patients were aged ≥ 70 with untreated, stage IIIB-IV NSCLC and ECOG performance status 0-2. Primary endpoint was RR. Secondary endpoints included median progression free and overall survival (PFS, OS) and correlatives of PDGFR pathway activation. Baseline Charlson Comorbidity Index (CCI) and Vulnerable Elder Survey-13 (VES-13) were correlated with outcomes. RESULTS: Thirty-four patients with median age 75 enrolled. Eleven of 29 (38%) were frail by VES-13 score. Overall RR was 11/34 (32%; 95% CI 17%-51%), meeting the primary endpoint. Median PFS and OS were 3.6 and 7.3 months, respectively. High tumoral PDGF-B expression predicted inferior PFS. Frail patients by VES-13 had significantly worse median PFS (3.2 vs. 4.5 months; p=0.02) and OS (4.8 vs. 12 months; p=0.02) than non-frail. CONCLUSIONS: The combination of imatinib and paclitaxel had encouraging activity as measured by the primary endpoint of RR. However, PFS and OS were typical for elderly patients treated with single agent chemotherapy and the regimen is not recommended for further study. Adjunct imatinib did not overcome the established association of tumoral PDGF-B expression with inferior PFS. VES-13 was a powerful predictor of poor survival outcomes. Frailty should be further studied as a predictor of non-benefit from chemotherapy. TRIAL REGISTRATION: ClinicalTrials.gov NCT01011075

Large-scale risk prediction applied to Genetic Analysis Workshop 17 mini-exome sequence data

We consider the application of Efron’s empirical Bayes classification method to risk prediction in a genome-wide association study using the Genetic Analysis Workshop 17 (GAW17) data. A major advantage of using this method is that the effect size distribution for the set of possible features is empirically estimated and that all subsequent parameter estimation and risk prediction is guided by this distribution. Here, we generalize Efron’s method to allow for some of the peculiarities of the GAW17 data. In particular, we introduce two ways to extend Efron’s model: a weighted empirical Bayes model and a joint covariance model that allows the model to properly incorporate the annotation information of single-nucleotide polymorphisms (SNPs). In the course of our analysis, we examine several aspects of the possible simulation model, including the identity of the most important genes, the differing effects of synonymous and nonsynonymous SNPs, and the relative roles of covariates and genes in conferring disease risk. Finally, we compare the three methods to each other and to other classifiers (random forest and neural network)

Incidence Rate for Hantavirus Infections without Pulmonary Syndrome, Panama

During 2001–2007, to determine incidence of all hantavirus infections, including those without pulmonary syndrome, in western Panama, we conducted 11 communitywide surveys. Among 1,129 persons, antibody prevalence was 16.5%–60.4%. Repeat surveys of 476 found that patients who seroconverted outnumbered patients with hantavirus pulmonary syndrome by 14 to 1